Sarcopenia | CHOP Research Institute
 

Sarcopenia

Researchers at CHOP are recruiting patients diagnosed with either acute leukemia (myeloid, lymphoid), myelodysplastic syndromes, or aplastic anemia and treated with allogeneic hematopoietic cell transplantation (HCT) within the past 6-48 months.

Published on
Jun 8, 2022
CHOP researchers are leading IAMFIT, a clinical study testing an exercise intervention to enhance lifelong health for young HCT survivors.

The Roizen Lab aims to understand non-calciometabolic vitamin D effects and to use this understanding to design new therapies for common diseases like sarcopenia and obesity.